![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF |
| Obstructive Lung Diseases |
|
Free Subscription
1 Allergy |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Obstructive Lung Diseases is free of charge.
Longer Asthma Duration Is Associated With Elevated Non-T2 Sputum Biomarkers and
Reduced T2 Inflammation in Severe Asthma.
Allergy. 2026 Jul 9. doi: 10.1111/all.70436.
PubMed
Abstract available
Eosinophil-derived breath biomarkers and response to anti-IL-5/5R biologics in
severe asthma.
Am J Respir Crit Care Med. 2026 Jul 8:aamag329. doi: 10.1093.
PubMed
New Pharmaceutical Options for Patients with Allergic and Asthma-Related
Diseases: Balancing Effectiveness and Safety in Selection of Specific Therapies.
Ann Allergy Asthma Immunol. 2026 Jul 8:S1081-1206(26)00335.
PubMed
Abstract available
Consensus Document on the Multidisciplinary Management of Advanced-Stage
Respiratory Diseases.
Arch Bronconeumol. 2026;62:481-498.
PubMed
Abstract available
Aspiration and GERD in Bronchiectasis: Bridging Pulmonology, Gastroenterology,
and Otolaryngology in an At-Risk Population.
Chest. 2026 Jul 9:S0012-3692(26)00957-8. doi: 10.1016/j.chest.2026.
PubMed
Abstract available
Hypereosinophilia With Pseudomonas aeruginosa Infection in Patients With Asthma
on Anti-Inteleurkin-5 Biologics.
Chest. 2026;170:e1-e4.
PubMed
Abstract available
Does Inhaled Marijuana Use Have an Adverse Effect On Asthma?: An Incomplete
Answer.
Chest. 2026;170:3-5.
PubMed
Prevalence, detection, and trajectory of combined pulmonary fibrosis and
emphysema.
Chest. 2026 Jul 7:S0012-3692(26)00952-9. doi: 10.1016/j.chest.2026.
PubMed
Abstract available
Efficacy and Safety of Ensifentrine in Chinese Participants With COPD: The
ENHANCE-CHINA Randomized Clinical Trial.
Chest. 2026;170:88-100.
PubMed
Abstract available
Can Posttransplant Cyclophosphamide Reduce Bronchiolitis Obliterans Syndrome Risk
Through Chronic Graft vs Host Disease Prevention?: A Multicenter Cohort Study.
Chest. 2026;170:169-180.
PubMed
Abstract available
The Epidemiology of Cryptogenic Organizing Pneumonia: An Analysis of Data From
the Nationwide Inpatient Sample.
Chest. 2026;170:149-156.
PubMed
Abstract available
Win Ratio Analysis to Clarify Clinical Benefits: A Post Hoc Analysis of Phase 3
BOREAS and NOTUS (Two Pivotal Studies to Assess the Efficacy, Safety, and
Tolerability of Dupilumab in Patients With Moderate-to-Severe COPD With Type 2
Inflammation).
Chest. 2026;170:76-87.
PubMed
Abstract available
Maternal Diabetes and Subsequent Risk of Asthma and Atopic Dermatitis in
Offspring: A Binational Birth Cohort Study in South Korea and Japan.
Clin Exp Allergy. 2026 Jul 5. doi: 10.1111/cea.70385.
PubMed
Persistent homology analysis of longitudinal computed tomography fibrotic
features in COPD.
Eur Respir J. 2026;68:2501630.
PubMed
Abstract available
Critical flaws in: "Dupilumab and lymphoma risk among patients with asthma: a
population-based cohort study".
Eur Respir J. 2026;68:2501565.
PubMed
Abstract available
Post-GWAS Variant-to-Function Challenges in Asthma Research.
J Allergy Clin Immunol. 2026 Jul 9:S0091-6749(26)00483.
PubMed
Abstract available
Association between Dietary Intake of Live Microbes and Asthma Risk in Children
and Adolescents Aged 6-15 Years: A Cross-sectional analysis.
J Asthma. 2026 Jul 10:1-14. doi: 10.1080/02770903.2026.2701395.
PubMed
Abstract available
Negative association between asthma and tuberculosis: The mediating effect of
albumin.
J Asthma. 2026 Jul 10:1-13. doi: 10.1080/02770903.2026.2701401.
PubMed
Abstract available
Proton Pump Inhibitor Target Genes and Asthma Susceptibility: A Mendelian
Randomization Study with Identification of IL-2 as a Potential Mediator.
J Asthma. 2026 Jul 8:1-17. doi: 10.1080/02770903.2026.2700538.
PubMed
Abstract available
Perceptions, Attitudes, and Real-World Use of FENO in Allergy and Asthma
Practice: Results of a National Survey from Turkiye.
J Asthma. 2026 Jul 8:1-16. doi: 10.1080/02770903.2026.2701397.
PubMed
Abstract available
Long-term efficacy and safety of dupilumab in patients enrolled from Latin
American centers from the open-label extension LIBERTY ASTHMA TRAVERSE study.
J Asthma. 2026 Jul 7:1-16. doi: 10.1080/02770903.2026.2696570.
PubMed
Abstract available
Impact of biologic therapy on ICS/LABA adherence in severe asthma: assessment of
inhaler therapy adherence remains imperative.
J Asthma. 2026 Jul 7:1-8. doi: 10.1080/02770903.2026.2696582.
PubMed
Abstract available
IL-10 promoter polymorphisms (-1082G > A, -819C > T and - 592 C > A) and
pediatric asthma susceptibility in a Mauritanian population.
J Asthma. 2026 Jul 9:1-12. doi: 10.1080/02770903.2026.2696576.
PubMed
Abstract available
Approval of Respiratory Biologics Linked to Decline in Asthma Exacerbations.
JAMA. 2026 Jul 10. doi: 10.1001/jama.2026.9473.
PubMed
Efficacy and Safety of Biologic Therapies for Uncontrolled Asthma: An Overview of
Systematic Reviews.
Pediatr Pulmonol. 2026;61:e71727.
PubMed
Abstract available
ASTHMA AT THE CROSSROADS: FROM ANTI-TNF-alpha SETBACKS TO NEXT-GENERATION BIOLOGICS
TARGETING TYPE 1 AND TYPE 2 INFLAMMATION.
Respir Med. 2026 Jul 9:109033. doi: 10.1016/j.rmed.2026.109033.
PubMed
Abstract available
Depemokimab: toward biannual biologic therapy for severe eosinophilic asthma.
Respir Res. 2026;27:276.
PubMed
Abstract available
Thank you for your interest in scientific medicine.